Watch Ticker

2seventy bio, Inc. Common Stock

Go to 2seventy bio, Inc. Common Stock Website

$4.96

(%)

Live

Previous Close

$4.96

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$254.5 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

On CRISPR Therapeutics' (CRSP) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to the first sales numbers of its newly approved gene therapy, Casgevy.

Related tickers: VRTX, ANIP, CRSP, TSVT.

Read Full Article

Zacks Equity Research - Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales

Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.

Related tickers: REGN, SNY, BAYRY, TSVT.

Read Full Article

Trending Tickers

CRIS

XNAS

$16.20

(%)

CVNA

XNYS

$116.66

(%)

LASE

XNAS

$2.13

(%)

SQ

XNYS

$71.60

(%)

MLGO

XNAS

$0.00

(%)